Logo image of BH

BIGLARI HOLDINGS INC-B (BH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BH - US08986R3093 - Common Stock

460.2 USD
+1.26 (+0.27%)
Last: 1/16/2026, 8:04:00 PM
460.2 USD
0 (0%)
After Hours: 1/16/2026, 8:04:00 PM
Fundamental Rating

3

BH gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. BH has a great financial health rating, but its profitability evaluates not so good. BH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • BH had positive earnings in the past year.
  • BH had a positive operating cash flow in the past year.
  • In multiple years BH reported negative net income over the last 5 years.
  • In the past 5 years BH always reported a positive cash flow from operatings.
BH Yearly Net Income VS EBIT VS OCF VS FCFBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

  • BH has a worse Return On Assets (0.19%) than 60.90% of its industry peers.
  • Looking at the Return On Equity, with a value of 0.36%, BH is in line with its industry, outperforming 53.38% of the companies in the same industry.
  • BH's Return On Invested Capital of 2.19% is on the low side compared to the rest of the industry. BH is outperformed by 65.41% of its industry peers.
  • BH had an Average Return On Invested Capital over the past 3 years of 4.28%. This is significantly below the industry average of 10.34%.
Industry RankSector Rank
ROA 0.19%
ROE 0.36%
ROIC 2.19%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
BH Yearly ROA, ROE, ROICBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

  • BH has a Profit Margin (0.54%) which is comparable to the rest of the industry.
  • BH has a Operating Margin (6.19%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of BH has grown nicely.
  • Looking at the Gross Margin, with a value of 38.28%, BH is doing worse than 65.41% of the companies in the same industry.
  • BH's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.19%
PM (TTM) 0.54%
GM 38.28%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
BH Yearly Profit, Operating, Gross MarginsBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

7

2. Health

2.1 Basic Checks

  • BH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, BH has about the same amount of shares outstanding.
  • Compared to 5 years ago, BH has less shares outstanding
  • The debt/assets ratio for BH is higher compared to a year ago.
BH Yearly Shares OutstandingBH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
BH Yearly Total Debt VS Total AssetsBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

  • BH has an Altman-Z score of 2.81. This is not the best score and indicates that BH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BH's Altman-Z score of 2.81 is fine compared to the rest of the industry. BH outperforms 70.68% of its industry peers.
  • The Debt to FCF ratio of BH is 3.77, which is a good value as it means it would take BH, 3.77 years of fcf income to pay off all of its debts.
  • BH has a better Debt to FCF ratio (3.77) than 81.95% of its industry peers.
  • BH has a Debt/Equity ratio of 0.48. This is a healthy value indicating a solid balance between debt and equity.
  • BH has a better Debt to Equity ratio (0.48) than 68.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.77
Altman-Z 2.81
ROIC/WACC0.26
WACC8.52%
BH Yearly LT Debt VS Equity VS FCFBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

  • BH has a Current Ratio of 2.83. This indicates that BH is financially healthy and has no problem in meeting its short term obligations.
  • BH has a Current ratio of 2.83. This is amongst the best in the industry. BH outperforms 92.48% of its industry peers.
  • BH has a Quick Ratio of 2.80. This indicates that BH is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 2.80, BH belongs to the best of the industry, outperforming 93.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.8
BH Yearly Current Assets VS Current LiabilitesBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

0

3. Growth

3.1 Past

  • The earnings per share for BH have decreased strongly by -94.31% in the last year.
  • Looking at the last year, BH shows a small growth in Revenue. The Revenue has grown by 6.87% in the last year.
  • BH shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -11.55% yearly.
EPS 1Y (TTM)-94.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.77%
Revenue 1Y (TTM)6.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.32%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BH Yearly Revenue VS EstimatesBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
BH Yearly EPS VS EstimatesBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 -2 -4 -6 -8

2

4. Valuation

4.1 Price/Earnings Ratio

  • BH is valuated quite expensively with a Price/Earnings ratio of 90.24.
  • Compared to the rest of the industry, the Price/Earnings ratio of BH is on the same level as its industry peers.
  • BH is valuated expensively when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 90.24
Fwd PE N/A
BH Price Earnings VS Forward Price EarningsBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • BH's Enterprise Value to EBITDA is on the same level as the industry average.
  • Based on the Price/Free Cash Flow ratio, BH is valued cheaper than 91.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12.93
EV/EBITDA 13.87
BH Per share dataBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • BH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BIGLARI HOLDINGS INC-B

NYSE:BH (1/16/2026, 8:04:00 PM)

After market: 460.2 0 (0%)

460.2

+1.26 (+0.27%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07
Earnings (Next)02-27
Inst Owners93.18%
Inst Owner Change0%
Ins Owners0.4%
Ins Owner Change0%
Market Cap1.05B
Revenue(TTM)386.51M
Net Income(TTM)2.09M
Analysts43.33
Price TargetN/A
Short Float %40.02%
Short Ratio1.26
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 90.24
Fwd PE N/A
P/S 2.71
P/FCF 12.93
P/OCF 9.79
P/B 1.81
P/tB 2.08
EV/EBITDA 13.87
EPS(TTM)5.1
EY1.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)35.59
FCFY7.73%
OCF(TTM)47.01
OCFY10.22%
SpS169.52
BVpS254.51
TBVpS221.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number170.89
Profitability
Industry RankSector Rank
ROA 0.19%
ROE 0.36%
ROCE 2.55%
ROIC 2.19%
ROICexc 3.61%
ROICexgc 4.17%
OM 6.19%
PM (TTM) 0.54%
GM 38.28%
FCFM 20.99%
ROA(3y)0.71%
ROA(5y)0.47%
ROE(3y)0.87%
ROE(5y)0.38%
ROIC(3y)4.28%
ROIC(5y)4.07%
ROICexc(3y)5.11%
ROICexc(5y)4.86%
ROICexgc(3y)5.84%
ROICexgc(5y)5.56%
ROCE(3y)5.05%
ROCE(5y)4.78%
ROICexgc growth 3Y-14.08%
ROICexgc growth 5Y44.59%
ROICexc growth 3Y-14.03%
ROICexc growth 5Y43.14%
OM growth 3Y-13.98%
OM growth 5Y50.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.62%
GM growth 5Y13.62%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 3.77
Debt/EBITDA 4.35
Cap/Depr 64.86%
Cap/Sales 6.74%
Interest Coverage 250
Cash Conversion 167.28%
Profit Quality 3878.39%
Current Ratio 2.83
Quick Ratio 2.8
Altman-Z 2.81
F-Score4
WACC8.52%
ROIC/WACC0.26
Cap/Depr(3y)72.81%
Cap/Depr(5y)99.4%
Cap/Sales(3y)7.64%
Cap/Sales(5y)9.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-117.77%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.87%
Revenue growth 3Y-0.36%
Revenue growth 5Y-11.55%
Sales Q2Q%10.32%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-1.66%
EBIT growth 3Y-14.29%
EBIT growth 5Y33.25%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.75%
FCF growth 3Y-51.22%
FCF growth 5Y-24.16%
OCF growth 1Y39.79%
OCF growth 3Y-39.9%
OCF growth 5Y-11.92%

BIGLARI HOLDINGS INC-B / BH FAQ

What is the fundamental rating for BH stock?

ChartMill assigns a fundamental rating of 3 / 10 to BH.


What is the valuation status for BH stock?

ChartMill assigns a valuation rating of 2 / 10 to BIGLARI HOLDINGS INC-B (BH). This can be considered as Overvalued.


How profitable is BIGLARI HOLDINGS INC-B (BH) stock?

BIGLARI HOLDINGS INC-B (BH) has a profitability rating of 3 / 10.


What is the financial health of BIGLARI HOLDINGS INC-B (BH) stock?

The financial health rating of BIGLARI HOLDINGS INC-B (BH) is 7 / 10.